| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2008-10-15 12:12:16 UTC |
|---|
| Update Date | 2022-03-07 02:51:02 UTC |
|---|
| HMDB ID | HMDB0010730 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 3-Oxotetradecanoic acid |
|---|
| Description | 3-Oxo-tetradecanoic acid is an intermediate in fatty acid biosynthesis. Specifically, 3-Oxo-tetradecanoic acid is converted from Malonic acid via three enzymes; 3-oxoacyl-[acyl-carrier-protein] synthase, fatty-acid Synthase and beta-ketoacyl -acyl-carrier-protein synthase II. (EC:2.3.1.41, E.C: 2.3.1.85, 2.3.1.179). In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation. |
|---|
| Structure | InChI=1S/C14H26O3/c1-2-3-4-5-6-7-8-9-10-11-13(15)12-14(16)17/h2-12H2,1H3,(H,16,17) |
|---|
| Synonyms | | Value | Source |
|---|
| 3-Oxotetradecanoate | Generator | | 3-Oxomyristic acid | ChEBI | | 3-Oxomyristate | Generator | | 3-oxo-Tetradecanoate | HMDB | | 3-oxo-Tetradecanoic acid | HMDB |
|
|---|
| Chemical Formula | C14H26O3 |
|---|
| Average Molecular Weight | 242.3544 |
|---|
| Monoisotopic Molecular Weight | 242.188194698 |
|---|
| IUPAC Name | 3-oxotetradecanoic acid |
|---|
| Traditional Name | 3-oxotetradecanoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCCCCCCCCCC(=O)CC(O)=O |
|---|
| InChI Identifier | InChI=1S/C14H26O3/c1-2-3-4-5-6-7-8-9-10-11-13(15)12-14(16)17/h2-12H2,1H3,(H,16,17) |
|---|
| InChI Key | XLKOZYOVXNPWGT-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty acids and conjugates |
|---|
| Direct Parent | Long-chain fatty acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Long-chain fatty acid
- Beta-keto acid
- Keto fatty acid
- Beta-hydroxy ketone
- Keto acid
- 1,3-dicarbonyl compound
- Ketone
- Carboxylic acid
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Organooxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organic oxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.77 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 18.1061 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.3 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 31.6 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2562.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 496.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 199.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 263.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 475.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 772.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 762.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 86.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1669.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 509.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1561.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 559.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 427.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 554.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 420.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 14.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-Oxotetradecanoic acid,1TMS,isomer #1 | CCCCCCCCCCCC(=O)CC(=O)O[Si](C)(C)C | 1950.7 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,1TMS,isomer #2 | CCCCCCCCCCCC(=CC(=O)O)O[Si](C)(C)C | 2082.1 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,1TMS,isomer #3 | CCCCCCCCCCC=C(CC(=O)O)O[Si](C)(C)C | 2029.4 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TMS,isomer #1 | CCCCCCCCCCCC(=CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2107.6 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TMS,isomer #1 | CCCCCCCCCCCC(=CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2102.4 | Standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TMS,isomer #1 | CCCCCCCCCCCC(=CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2073.8 | Standard polar | 33892256 | | 3-Oxotetradecanoic acid,2TMS,isomer #2 | CCCCCCCCCCC=C(CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2095.3 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TMS,isomer #2 | CCCCCCCCCCC=C(CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2103.8 | Standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TMS,isomer #2 | CCCCCCCCCCC=C(CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2096.0 | Standard polar | 33892256 | | 3-Oxotetradecanoic acid,1TBDMS,isomer #1 | CCCCCCCCCCCC(=O)CC(=O)O[Si](C)(C)C(C)(C)C | 2189.9 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,1TBDMS,isomer #2 | CCCCCCCCCCCC(=CC(=O)O)O[Si](C)(C)C(C)(C)C | 2325.9 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,1TBDMS,isomer #3 | CCCCCCCCCCC=C(CC(=O)O)O[Si](C)(C)C(C)(C)C | 2278.8 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TBDMS,isomer #1 | CCCCCCCCCCCC(=CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2583.2 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TBDMS,isomer #1 | CCCCCCCCCCCC(=CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2464.5 | Standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TBDMS,isomer #1 | CCCCCCCCCCCC(=CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2356.8 | Standard polar | 33892256 | | 3-Oxotetradecanoic acid,2TBDMS,isomer #2 | CCCCCCCCCCC=C(CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2556.9 | Semi standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TBDMS,isomer #2 | CCCCCCCCCCC=C(CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2472.1 | Standard non polar | 33892256 | | 3-Oxotetradecanoic acid,2TBDMS,isomer #2 | CCCCCCCCCCC=C(CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2367.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 3-Oxotetradecanoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-9300000000-caec0675bb7cc4bf645e | 2016-09-22 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Oxotetradecanoic acid GC-MS (1 TMS) - 70eV, Positive | splash10-05bu-9240000000-9f5c74b9b22322bac095 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Oxotetradecanoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 10V, Positive-QTOF | splash10-002f-0290000000-8e607f12b728cd17d0eb | 2016-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 20V, Positive-QTOF | splash10-004m-4920000000-4703c7195a11feeb2b5a | 2016-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 40V, Positive-QTOF | splash10-052f-9300000000-a7e2659c4534794225d0 | 2016-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 10V, Negative-QTOF | splash10-0007-1890000000-62a40531fb987abfd8b6 | 2016-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 20V, Negative-QTOF | splash10-0002-3910000000-d4867d427aeab7a02553 | 2016-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 40V, Negative-QTOF | splash10-0a4i-9300000000-4b25931f846416282cca | 2016-09-14 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 10V, Positive-QTOF | splash10-0006-9670000000-20164b0847d143f44c74 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 20V, Positive-QTOF | splash10-05nb-9200000000-5468639cd8cec19d4dcd | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 40V, Positive-QTOF | splash10-0a5d-9000000000-ed47cbde55f8e1b78e23 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 10V, Negative-QTOF | splash10-052f-6090000000-a84a5a93ec99d19f1719 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 20V, Negative-QTOF | splash10-0a4i-9010000000-6a10d917408e88ed0e4b | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Oxotetradecanoic acid 40V, Negative-QTOF | splash10-0006-9000000000-f1c0182976e7a431dba9 | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| Disease References | | Iron deficiency |
|---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
| | Ulcerative colitis |
|---|
- Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
|
|
|---|